Skip to main content
Retour
Watch Compare

Senti Biosciences, Inc.

Qualité des données : 100%
SNTI
NASDAQ Manufacturing Chemicals
0,87 €
▲ 0,00 € (0,38%)
Cap. Boursière: 26,82 M
Prix
0,86 €
Cap. Boursière
26,82 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -43,64 M
Capital intensive — 890,91% of revenue goes to capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-374,93%
En dessous de la moyenne du secteur (-54,01%)
ROIC-109,54%
Net Margin-279263,64%
Op. Margin-312631,82%

Sécurité

Debt / Equity
N/A
Current Ratio1,51
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-0,44 | -0,98
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio3,30
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B 3,3 1,6
ROE % -374,9 -54,0
Net Margin % -279263,6 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

4 analystes
Buy
Actuel
0,87 €
+1160.0%
Objectif
11,00 €
6,00 €
11,50 €
15,00 €
Prévisions
P/E Prévisionnel -0,98
BPA Prévisionnel -0,90 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,90 €
-1,25 € – -0,54 €
 0,0 2
FY2026 -1,09 €
-1,38 € – -0,68 €
 0,0 3

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,47 € -0,53 € -12,0%
Q32025 -0,57 € -0,69 € -21,8%
Q22025 -0,90 € -0,56 € +37,8%
Q12025 -0,56 € -1,41 € -151,8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) -90,73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 22 000,0 Net Income (TTM) -61,44 M
ROE -374,93% ROA -101,36%
Gross Margin N/A Operating Margin -312631,82%
Net Margin -279263,64% Free Cash Flow (TTM) -43,64 M
ROIC -109,54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,51
Interest Coverage N/A Asset Turnover 0,00
Working Capital 6,13 M Tangible Book Value 8,12 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,44 Forward P/E -0,98
P/B Ratio 3,30 P/S Ratio 1218,88
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -162,74%
Market Cap 26,82 M Enterprise Value 14,57 M
Per Share
EPS (Diluted TTM) -2,73 Revenue / Share 0,00
FCF / Share -1,40 OCF / Share -1,39
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 890,91% FCF Conversion 71,03%
SBC-Adj. FCF -48,59 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue 22 000,0 0,0 2,56 M — 4,29 M
Net Income -61,44 M -52,79 M -71,06 M -3,86 M -58,21 M
EPS (Diluted) -2,73 -12,03 -1,60 — -2,23
Gross Profit — — — — —
Operating Income -68,78 M -61,04 M -92,73 M -3,87 M -70,63 M
EBITDA — — — — —
R&D Expenses 37,59 M 34,36 M 32,15 M — 34,07 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 — — 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 51,22 M 97,84 M 119,48 M 231,46 M 180,79 M
Total Liabilities 45,63 M 47,09 M 52,57 M 10,33 M 53,53 M
Shareholders' Equity 5,59 M 25,65 M 66,91 M -8,88 M 127,26 M
Total Debt — — — — —
Cash & Equivalents 16,42 M 48,28 M 35,93 M 889 323,0 57,62 M
Current Assets 23,27 M 58,96 M 71,20 M 1,30 M 102,58 M
Current Liabilities 13,97 M 13,15 M 12,67 M 3,28 M 18,05 M